<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A9141201-5CB3-4A79-9688-91FA6160D936"><gtr:id>A9141201-5CB3-4A79-9688-91FA6160D936</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Davis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12010%2F4"><gtr:id>61A072C6-F835-4669-8439-BB672B1B9C5D</gtr:id><gtr:title>Biology of the leukocyte cell surface and a role for it in the treatment of autoimmune disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12010/4</gtr:grantReference><gtr:abstractText>The aim of the T-cell biology group, in its translational work, is to develop new antibodies for use as therapies in autoimmune diseases. To achieve this we are working towards an understanding of the biology of the leukocyte cell surface, and to apply this understanding to the development of new drug-like antibodies. Leukocytes are white blood cells that are involved in defending the body against infectious disease and foreign materials found in the blood and lymphatic circulatory systems. The surface of leukocytes is covered in protein molecules, some of which are receptors that interact with fragments of specific foreign proteins either from infectious agents or other foreign materials, such as allergens, or, as in the case of some autoimmune diseases, to self-antigens. When the receptors interact with their target molecules, we propose that they undergo a reorganization that causes them to trigger immune response pathways. If these pathways are triggered inappropriately, then autoimmune disease can develop. The process of receptor triggering by native ligands can be mimicked with antibodies, which means that, when we fully understand the process, we may be in a position to design new antibody-based receptor agonists for use in the treatment of autoimmune diseases.</gtr:abstractText><gtr:technicalSummary>Goals To understand the cell biology of the leukocyte surface and to use the insights to alter the behaviour of leukocytes in autoimmune settings. The T-cell biology group is working towards an understanding of the biology of the leukocyte surface and the mechanism of receptor triggering, both for its intrinsic cell biological interest and as the basis for developing new types of immunotherapy. For the last several years we have focused on understanding the composition of the T-cell surface and how receptors expressed there are organized and then ?triggered? by ligand binding (1-3). The expression of transcripts encoding known cell surface molecules by a human CD8+ T-cell clone was characterized by a transcriptomic approach (SAGE) and the results suggested that existing models of receptor triggering are unlikely to be wrong because key components remain to be discovered (1). Determination of an anti-CD28 superagonistic antibody Fab fragment bound to CD28 (2) provided insights as to how antibody superagonists work and incorporated CD28 into the family of receptors triggered via kinase/phosphatase segregation ? a family that includes the T cell receptor (for a review see reference 3). Assembly of proteins expressed at the cell surface has been studied by bioluminescence resonance energy transfer (BRET), which has been used to characterize the quaternary structures of cell surface molecules. Our new experimental framework for detecting transfected receptor dimers revealed that most proteins expressed at the cell surface are likely to be monomers, undermining the notion that important groups of receptors inexorably form dimers (4). Together with our collaborators we have established a new method for studying the organization of native receptor complexes (two-colour coincidence detection). Analysis of the composition of protein complexes on the surface of live T cells has shown that the TCR is monovalent (5). Recent work has focused on determination of the stoichiometries of each key component of the T cell triggering apparatus ? MHC class II, CD4, CD45 ? and these too have been shown to be monovalent (6). Future research plans Future work will concentrate on understanding receptor triggering by native ligands and by antibodies and to use this knowledge in the development of new receptor agonist-based therapeutic antibodies ? for example against inhibitory receptors such as PD-1 that suppress immune responses both in vivo and in vitro. A key objective is to target molecules that may offer new opportunities to intervene in autoimmunity. References: (1) Evans et al 2003 Immunity 19: 213 (2) Evans 2005 Nature Immmunol 6: 271 (3) Davis and van der Merwe 2006. Nature Immunol 7: 803 (4) James et al. 2006 Nature Methods 3: 1001 (5) James et al 2007 Proc Natl Acad Sci USA 104: 17662 (6) James et al. 2011 J Biol Chem. 2011 16:31993</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1233000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Stoichiometric analysis of GPCRs</gtr:description><gtr:id>7201992E-B6D9-4B01-805F-E6D4241C9C83</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>jNxA9xTTTMS-1</gtr:outcomeId><gtr:partnerContribution>The Klenerman laboratory in Cambridge analyses the organization of the G-coupled receptors using single molecule and super-resolution imaging</gtr:partnerContribution><gtr:piContribution>We are interested in the organization of G-coupled receptors and prepare different forms of them for analysis by single molecule and super-resolution imaging</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Single molecule analysis of T-cell activation</gtr:description><gtr:id>4F6CDDCC-A634-42B7-AF33-336910204DF6</gtr:id><gtr:impact>Publications:
James JR, White SS, Clarke RW, Johansen AM, Dunne PD, Sleep DL, Fitzgerald WJ, Davis SJ, Klenerman D. (2007) Single-molecule level analysis of the subunit composition of the T cell receptor on live T cells. Proc Natl Acad Sci U S A. 104, 17662-7. 

Dunne PD, Fernandes RA, McColl J, Yoon JW, James JR, Davis SJ, Klenerman D. (2009) DySCo: quantitating associations of membrane proteins using two-color single-molecule tracking. Biophys J. 97, L5-7.

James JR, McColl J, Oliveira MI, Dunne PD, Huang E, Jansson A, Nilsson P, Sleep DL, Gon&amp;ccedil;alves C, Morgan SH, Felce JH, Mahen R, Fernandes RA, Carmo AM, Klenerman D, Davis SJ. (2011) The T-cell receptor triggering apparatus is composed of monovalent or monomeric proteins. J Biol Chem. 286, 31993-2001.

Klenerman D, Korchev YE, Davis SJ. (2011) Imaging and characterisation of the surface of live cells. Curr Opin Chem Biol. 15, 696-703.</gtr:impact><gtr:outcomeId>TSAFCcU9cn4-1</gtr:outcomeId><gtr:partnerContribution>Professor Klenerman's laboratory has been testing the theory using single molecule and super-resolution imaging.</gtr:partnerContribution><gtr:piContribution>We have proposed a theory of receptor triggering in T-cells that is amenable to analysis by single molecule and super-resolution imaging.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Experimental Medicine</gtr:department><gtr:description>In vivo analysis of antibody superagonists</gtr:description><gtr:id>7BE8D428-5D6C-464E-9B4D-71B19B525AAB</gtr:id><gtr:impact>One excellent PhD thesis; publications to follow.</gtr:impact><gtr:outcomeId>WqQ2VTUGrgt-1</gtr:outcomeId><gtr:partnerContribution>Professor Richard Cornall is analysing the effects of the antibodies on the immune responses of these mice</gtr:partnerContribution><gtr:piContribution>We have generated potentially therapeutic antibodies and genetically engineered mice for the analysis of the effects of these antibodies on the mouse immune system.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford University Clinical Academic Graduate School (OUCAGS)</gtr:department><gtr:description>Analysis of the resting organization of T cell signaling molecules</gtr:description><gtr:id>0D9184C3-5E8C-41AA-B57E-719691E84B27</gtr:id><gtr:impact>The study is approaching completion, whereupon we are planning to submit a paper to a high-impact journal.</gtr:impact><gtr:outcomeId>5461e878ac1371.28616326-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators are expert in the use of state of the art super-resolution imaging tools, which have allowed us to interrogate the organization of signaling proteins in T cells.</gtr:partnerContribution><gtr:piContribution>We have provided the biological know-how and rationale at the heart of the experiments.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Hosting high-school students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>865F0E9E-D283-4326-811A-3913246F1CBB</gtr:id><gtr:impact>Each year we host 2-3 students for one week in the laboratory. They get to participate in on-going research and to do their own experiments. They leave with a copy of the &amp;quot;Double Helix&amp;quot; by JD Watson in order to inspire them to consider a life of scientific discovery.

These visits are always enjoyed by al concerned, and the students invariably leave more favourably disposed to a life in science.</gtr:impact><gtr:outcomeId>soET2ezkedp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting high-school students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7C7E334-D3AB-49D1-91CE-FBCD9F4BD96F</gtr:id><gtr:impact>Both years two high-school students speant a week in the laboratory doing experiments and getting a feel for how scientists spend their days. We also discussed with them the reasons why a life in science is so worthwhile.</gtr:impact><gtr:outcomeId>58c81b3b64caf2.82572227</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A6533646-EAB1-413E-B143-F02A3DB8EBFE</gtr:id><gtr:impact>Over the course of the 2 days, 500 people attended the MRC stall in the main auditorium, which was co-run by a post-doctoral scientist from this laboratory.

We were not informed of the results of any follow-up.</gtr:impact><gtr:outcomeId>aUrxRd8j88u</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2689497</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Fellowship (Renewal)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>198E6916-FAF2-4129-81DD-979A6F39BB25</gtr:id><gtr:outcomeId>KHATPeD7Nkv</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have generated a &amp;quot;humanised&amp;quot; knock-in mouse expressing human PD-1, which is useful for studying the the anti-tumour effects of therapeutic reagents targeting human PD-1.</gtr:description><gtr:grantRef>MC_UU_12010/4</gtr:grantRef><gtr:id>D08BBF8E-BD05-4474-AA61-9A68C9E3536C</gtr:id><gtr:impact>The mouse is in heavy use in our own research on receptor agonists.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>5461f37338de39.36757126</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>PD-1 &amp;quot;knock-in&amp;quot; mouse</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Methodology for agonizing receptors</gtr:description><gtr:grantRef>MC_UU_12010/4</gtr:grantRef><gtr:id>A046B40A-C505-4C8E-BBF0-EEEA2192130B</gtr:id><gtr:impact>The development was used in part to leverage new research funding and the expansion fo the translational programme.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c81c243dd845.40241523</gtr:outcomeId><gtr:patentId>WO2005066867</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>RECEPTOR MODULATORS&amp;nbsp;</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Antibodies capable of superagonising PD-1.</gtr:description><gtr:grantRef>MC_UU_12010/4</gtr:grantRef><gtr:id>F1AE08AF-9C7A-4A31-8B0B-5CCCA41553BC</gtr:id><gtr:impact>The patent has been used to leverage new research funding for the expansion of the superagonist programme.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c81d72cfe538.81435407</gtr:outcomeId><gtr:patentId>WO2010029434</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>PD-1 SPECIFIC ANTIBODIES AND USES THEREOF</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Antibodies with receptor agonising activity</gtr:description><gtr:grantRef>MC_UU_12010/4</gtr:grantRef><gtr:id>FC68D7FF-C6D4-4839-BCBB-A194693A5315</gtr:id><gtr:impact>The patent has been used to leverage new research funding for the expansion of the superagonist programme.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c81d13c31f97.97058159</gtr:outcomeId><gtr:patentId>WO2010029435	</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>PD-1 SPECIFIC ANTIBODIES AND USES THEREOF</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Antibodies that superagonise the receptor PD-1.</gtr:description><gtr:grantRef>MC_UU_12010/4</gtr:grantRef><gtr:id>B5BA5175-B6F6-4175-9E3D-FD0C347F5840</gtr:id><gtr:impact>The patent has been used to leverage new research funding for the expansion of the superagonist programme.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c81dd6bf35b1.47145618</gtr:outcomeId><gtr:patentId>WO2010029435 B2</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>PD-1 SPECIFIC ANTIBODIES AND USES THEREOF</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>We have developed a method to induce inhibitory signaling in cells that express PD-1, using antibodies. We are presently broadening the concept to include new potential targets and seeking industrial partners to license and develop the technology for the treatment of inflammatory disease. We are also testing, using in vivo models, whether the antibodies might be useful for suppressing autoimmune colitis.</gtr:description><gtr:id>C8419AB7-8FA2-4F71-9FC9-B062A92A8F90</gtr:id><gtr:impact>It is possible that the invention may provide the basis for developing a new class of therapeutic antibodies.</gtr:impact><gtr:outcomeId>UAEi7X6Hn61</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Antibody superagonism</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Software for the analysis and qunatification of calcium responses in T cells</gtr:description><gtr:id>48C8C574-E632-4D97-8D80-B0FA371691C9</gtr:id><gtr:impact>Contributions to submitted and forthcoming publications</gtr:impact><gtr:outcomeId>56dd81f55c0720.95732827</gtr:outcomeId><gtr:title>CalQuo</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>487C9E71-2B6E-4B4C-97FC-3EAC61038B8F</gtr:id><gtr:title>Macrophages: micromanagers of antagonistic signaling nanoclusters.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ea5bd09790c9711c03ed51856154b8"><gtr:id>c9ea5bd09790c9711c03ed51856154b8</gtr:id><gtr:otherNames>Eggeling C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>5aaa3ce5bae218.27265374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C06880-BD0D-4D4E-87AD-653D088F1443</gtr:id><gtr:title>T cell receptors are structures capable of initiating signaling in the absence of large conformational rearrangements.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4540e216a0aaa561123955e734cd2b4"><gtr:id>f4540e216a0aaa561123955e734cd2b4</gtr:id><gtr:otherNames>Fernandes RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15344_24_22262845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB965BD-BBF7-4B1A-B9E2-951850AC8875</gtr:id><gtr:title>IL-2 and IL-15 signaling complexes: different but the same.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e10b2fde191519c6c6a9b38d5fda922"><gtr:id>0e10b2fde191519c6c6a9b38d5fda922</gtr:id><gtr:otherNames>Ikemizu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>pm_15344_24_23160210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69028C29-860F-4AEE-87A8-FC5E42B7F908</gtr:id><gtr:title>A streamlined implementation of the glutamine synthetase-based protein expression system.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8564bfa53ae6b4a72f7817544a1510f"><gtr:id>c8564bfa53ae6b4a72f7817544a1510f</gtr:id><gtr:otherNames>Knox R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>pm_15344_24_24063773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6C473F5-5597-4695-AA5D-EC356B315C67</gtr:id><gtr:title>andkinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ef586f0ee752b9a48fb0607626bbadf"><gtr:id>8ef586f0ee752b9a48fb0607626bbadf</gtr:id><gtr:otherNames>Li K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5aaa3dd70fcfa2.61857695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F1B1894-12F8-4905-9528-D238158F5FC6</gtr:id><gtr:title>Receptor Quaternary Organization Explains G&amp;nbsp;Protein-Coupled Receptor Family Structure.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24fd494bad1d615828960afb10f9da01"><gtr:id>24fd494bad1d615828960afb10f9da01</gtr:id><gtr:otherNames>Felce JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa3ce5517f93.84608972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9332DEB2-0E38-412A-B455-A0FD31A946FB</gtr:id><gtr:title>A quantitative comparison of single-dye tracking analysis tools using Monte Carlo simulations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31c648d38d66f50de331bc27c1d93ec9"><gtr:id>31c648d38d66f50de331bc27c1d93ec9</gtr:id><gtr:otherNames>Weimann L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15344_24_23737978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEDB23EE-6250-4193-9445-55ABFB0B7CEB</gtr:id><gtr:title>Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35343efd6a5a8ddc873888ac57c309d"><gtr:id>f35343efd6a5a8ddc873888ac57c309d</gtr:id><gtr:otherNames>J?nsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c80c60c60f72.28801905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B2257C6-E443-4526-A355-5D617D8833EB</gtr:id><gtr:title>Initiation of T cell signaling by CD45 segregation at 'close contacts'.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68a136b0edbb71d5410f0ee7a4e92009"><gtr:id>68a136b0edbb71d5410f0ee7a4e92009</gtr:id><gtr:otherNames>Chang VT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58c80c602fea07.89320773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>833612EE-D5CD-41F7-8C50-CB29AB7767E2</gtr:id><gtr:title>On the Control of TCR Phosphorylation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4540e216a0aaa561123955e734cd2b4"><gtr:id>f4540e216a0aaa561123955e734cd2b4</gtr:id><gtr:otherNames>Fernandes RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>pm_15344_24_22566970</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>601442E0-1929-4750-A2BD-5A44D4C71BE1</gtr:id><gtr:title>Single-Molecule Analysis of G Protein-Coupled Receptor Stoichiometry: Approaches and Limitations.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24fd494bad1d615828960afb10f9da01"><gtr:id>24fd494bad1d615828960afb10f9da01</gtr:id><gtr:otherNames>Felce JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>5aaa3ce4e0a152.78166486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82672A76-2C58-448B-838A-47B2DDBFD176</gtr:id><gtr:title>TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91d8bb4f92e8f39b6ef17c958444f58c"><gtr:id>91d8bb4f92e8f39b6ef17c958444f58c</gtr:id><gtr:otherNames>Gregory AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15344_24_22801493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9A06418-DEBB-4D13-B004-518B405C2CEB</gtr:id><gtr:title>Cytoskeletal actin dynamics shape a ramifying actin network underpinning immunological synapse formation.</gtr:title><gtr:parentPublicationTitle>Science advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fa74c28f49eec2ad36195d5e4c36b3"><gtr:id>40fa74c28f49eec2ad36195d5e4c36b3</gtr:id><gtr:otherNames>Fritzsche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2375-2548</gtr:issn><gtr:outcomeId>5aaa3ce59164e7.99998542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>947548E6-B0F6-4D30-88FC-24EC3F9169B5</gtr:id><gtr:title>Imaging the cell surface and its organization down to the level of single molecules.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce3d8d0ece9549d39e51cda27cd7c391"><gtr:id>ce3d8d0ece9549d39e51cda27cd7c391</gtr:id><gtr:otherNames>Klenerman D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_15344_24_23267181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23461FD8-30CA-4F45-B57A-15CF861A1572</gtr:id><gtr:title>PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7752c96eb0ccd7501a566cc489b3b3e1"><gtr:id>7752c96eb0ccd7501a566cc489b3b3e1</gtr:id><gtr:otherNames>Zinselmeyer BH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>pm_15344_24_23530125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E912EA-F588-4034-879D-7E71F3959077</gtr:id><gtr:title>Structure and interactions of the human programmed cell death 1 receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/997a67065fe01c77556039c47024ed9b"><gtr:id>997a67065fe01c77556039c47024ed9b</gtr:id><gtr:otherNames>Cheng X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15344_24_23417675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDD205FC-54A9-4493-8EF5-9D4F96BABC24</gtr:id><gtr:title>Unraveling receptor stoichiometry using bret.</gtr:title><gtr:parentPublicationTitle>Frontiers in endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24fd494bad1d615828960afb10f9da01"><gtr:id>24fd494bad1d615828960afb10f9da01</gtr:id><gtr:otherNames>Felce JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-2392</gtr:issn><gtr:outcomeId>pm_15344_24_22807923</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E34A9B32-6EAD-4B30-B445-F4B5DCC84579</gtr:id><gtr:title>CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cadd90672d2219ec4e0d99383d459ab"><gtr:id>7cadd90672d2219ec4e0d99383d459ab</gtr:id><gtr:otherNames>Oliveira MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_15344_24_21956609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9BEF032-8734-414B-9960-4F77AA5990C9</gtr:id><gtr:title>Capturing resting T cells: the perils of PLL.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97d260adad60effea16bc348cf968871"><gtr:id>97d260adad60effea16bc348cf968871</gtr:id><gtr:otherNames>Santos AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5aaa3ce4ac3fe8.14101536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A126B44B-8535-49D9-A55A-A9C33644D8AB</gtr:id><gtr:title>CalQuo: automated, simultaneous single-cell and population-level quantification of global intracellular Ca2+ responses.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40fa74c28f49eec2ad36195d5e4c36b3"><gtr:id>40fa74c28f49eec2ad36195d5e4c36b3</gtr:id><gtr:otherNames>Fritzsche M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56dd7d0689de27.52349833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84301FEF-D5B8-4A63-A07C-CCDEC5195A27</gtr:id><gtr:title>Super-Resolved Traction Force Microscopy (STFM).</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cea4da342fa8a6532074d6fdd4b6bd81"><gtr:id>cea4da342fa8a6532074d6fdd4b6bd81</gtr:id><gtr:otherNames>Colin-York H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn><gtr:outcomeId>56dd7d0645bf66.43802529</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12010/4</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>